Treatment with infliximab may contribute to the development of peripheral neuropathy among the patients with rheumatoid arthritis.
Kotyla
Przemyslaw J
PJ
Sliwinska-Kotyla
Bogna
B
Kucharz
Eugene J
EJ
D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D004576:Electromyography; D005260:Female; D006801:Humans; D000069285:Infliximab; D008297:Male; D010523:Peripheral Nervous System Diseases / Q000139:chemically induced*; D011446:Prospective Studies; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D000911:Antibodies, Monoclonal; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab